HCA HOUSTON HEALTHCARE SOUTHEAST — History
CCN 450097 | 3-year financial timeline | COVID resilience: 54/100
🛡️ Public data only — no PHI permitted on this instance.
$302M
Latest Revenue (FY2022)
+4.7%
Revenue CAGR (3yr)
18.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $275M | $296M | $302M | +1.9% | +4.7% |
| Operating Expenses | $224M | $249M | $245M | -1.6% | +4.7% |
| Operating Margin | 18.8% | 15.9% | 18.8% | +18.5% | +0.1% |
| Net Income | $52M | $47M | $57M | +20.8% | +4.8% |
| Licensed Beds | 259 | 241 | 253 | +5.0% | -1.2% |
| Total Patient Days | 69,766 | 74,140 | 69,613 | -6.1% | -0.1% |
| Medicare Day % | 16% | 12% | 12% | -1.5% | -13.3% |
| Medicaid Day % | 8% | 8% | 7% | -10.8% | -3.1% |
COVID Impact & Recovery
Resilience Score: 54/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +9.6% ($275M → $302M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▶ Stable
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.7%
This Hospital
+7.6%
State Avg
Latest Margin
18.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $315M | 18.9% |
| FY2024 (proj) | $328M | 18.9% |
| FY2025 (proj) | $341M | 18.9% |